Revefenacin is a selective muscarinic M3 receptor antagonist indicated for the treatment of chronic obstructive pulmonary disease (COPD), where it functions by relaxing airway smooth muscle to improve… Read more
Revefenacin is a selective muscarinic M3 receptor antagonist indicated for the treatment of chronic obstructive pulmonary disease (COPD), where it functions by relaxing airway smooth muscle to improve lung function. This category provides a comprehensive selection of Revefenacin reference standards, including the active pharmaceutical ingredient, identified impurities, potential metabolites, and stable isotope-labelled compounds. Pharmaceutical laboratories utilize these materials to support rigorous analytical testing, including impurity profiling and method validation during quality control processes. By providing high-quality reference materials, these compounds enable accurate quantification and structural identification, ensuring the efficacy and safety of drug formulations throughout the development cycle.